Schedule 13G ownership disclosure

ASPIRE BIOPHARMA HLDGS INC

Common Stock · CUSIP: 738920107

Event date: 2025-03-19

Filing-level shares
4,439,375.00
Percent of class
9.078%
  • Lance Friedman

    Shares: 4,439,375.00 · Class: 9.078%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001641172-25-001328
Form type
SCHEDULE 13G/A
Filer
Aspire Biopharma Holdings, Inc.
CIK
CIK 1847345
Filed
Mar 28, 2025
Reporting period
Mar 19, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub